CD5 and acute lymphoblastic leukemia: These researchers expressed third-generation CARs in the NK-92 cell line and demonstrated that, alongside steady expansion ex vivo, these CAR-NKs mediated exclusive and pronounced tumoricidal activity towards primary CD5+ cells of human T-ALL and PTCL and T cell lines including Jurkat, CCRF-CEM, and MOLT-4 [52].